This week we released 2025 updates on soft tissue #sarcoma with our local sarcoma expert @SamArmstrongMD Which of the following is a preferred approved treatment since 2023 for unresectable desmoid tumors? @HemOncFellows

PFS benefit with anlotinib+doxo and anlotinib maintenance. Lower than expected ORR in doxo arm and almost impossible to believe equivalence in toxicity between the arms. Same question as doxo+trabectedin: what if sequential single agent were used? #ASCO25

#ATOMIC phase 3 trial: stage 3 CRC adjuvant Atezolizumab + FOLFOX vs FOLFOX For fellows ➡️where it fits in to current practice All pts need MMR testing! 10-15% localized CRC are dMMR 🌟 new SOC 10% improvement in 3yr DFS but also good results for neoadj IO #NICHE2 #ASCO25

Our wonderful @TheFellowOnCall colleague Dr. Vivek Patel presenting final results from our multicenter randomized PODCAST-HOF trial And hot off the press today, publication in JCO: https://t.co/HAXv192gQe #ASCO25

Honored to be invited for the @OncMedEdCoP Keynote this AM w/ @OncBrothers! We discussed why, how, balance, topics, branding, research (podcast curriculum with @TheFellowOnCall to be presented at 1:15PM today), promotion, the changing landscape of med ed & digital ed #ASCO25

Honored to have been a keynote speaker this morning as half of @TwoOncDocs with @DrKarineTawagi along side @OncBrothers #asco2025 #MedEd

🤩 @TwoOncDocs @OncBrothers Happening NOW in S103 ‼️

Thank you all who joined Clinicals to Exams & guest appearance w/ baby Cary A few high-yield mnemonics: 🌟 ribociclib - “ribs” close to ❤️- Qtc; abemaciclib - “abs” - diarrhea 🌟 tumor marker half-life: Hcg -3 letters, 1-3d; AFP -alpha - 5 letters 5-7d Ready for #ASCO25 day 1!

Oncology Board Prep (#ClinicalsToExam) today with @TwoOncDocs! Then starting tomorrow, let’s take a dive into all the data coming at us from #ASCO25! #OncTwitter #MedTwitter

We are just 1 day away from our Clinicals to Exam board prep co-hosted with @OncBrothers We will cover high yield tips on: 🌟 board prep 101 🌟 breast CA 🌟 NSCLC 🌟 CRC 🌟 testicular CA 🌟 prostate CA Looking forward to seeing you all in Chicago tomorrow to kick off #ASCO25

🚨Calling all @asco #ASCO25 annual meeting attendees! Come join us in person for our annual #MedEd CoP event!! 🔔 Saturday May 31st 🔔 7:30-9:30 am 🔔 Room S103 ‼️Keynote speakers: @TwoOncDocs and @OncBrothers!! Can’t wait to see you there!! 🥰

Can’t wait to hear from @TwoOncDocs and @OncBrothers during this great session!! @SamArmstrongMD @DrKarineTawagi @RManochakian @Kathy_WalshMD @s_brond @IUCancerCenter @IUMedSchool @IUHemOnc

You know #ASCO25 is < 3 months away! It’s never too early to start planning, especially if you are going to be taking your boards! Onc Board Review, w/ @TwoOncDocs + @OncBrothers: 📅 May 29: theWit Chicago ✅ Register: https://t.co/fYCUDVBvPO #OncTwitter @SignifyMD

FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumor. Vimseltinib achieved a 40% ORR in #TGCT patients, significantly outperforming placebo in the MOTION trial. ⁦@TGCTSupportorg⁩ ⁦@Liferaftgroup⁩ #sarcoma

We released a new episode this week on exciting data to look forward to at #ASCOGU25 - a roundup of the data will be released next week 🌟 & the following will be back with more Myeloma updates 🧬 https://t.co/IikuXD4gJT

Tune in for 2 episodes with @StephenVLiu on Small Cell Lung Cancer! We discuss 🔑 pearls on risk factors, diagnostic work-up, staging and tx of both locoregional and metastatic #SCLC, options for relapsed/refractory disease & advice for trainees.

Very excited to see this in print! Such promising outcomes for immune cold #sarcomas with Botensilimab Plus Balstilimab https://t.co/U679Y5jlJi @Agenus_Bio @CUCancerCenter

Outstanding work from our liver transplant surgery team in 2024! 215 patient lives impacted! Top 5 in the country! Congrats!!

Congrats to all the new board certified Oncologists who found out this week they passed!😊 This week we had world expert Dr. Pat Loehrer @IUCancerCenter talk to us about Thymomas & Thymic Carcinomas. Next week he shares regimens for more advanced disease & advice for trainees

Open and enrolling here at @IUCancerCenter